The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from the University of Houston ...
5 hours ago
0
1
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in combating the resilient ...
Dec 19, 2023
0
2
Knee and hip replacements are increasing globally due to an aging population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next seven years. Post-surgery infections, ...
Oct 18, 2023
0
90
A team of biochemists at the University of Notre Dame has found a possible new way to treat patients infected with Clostridioides difficile, a type of bacteria that causes serious gastrointestinal problems. In their study, ...
A new study, published in the Cochrane Database of Systematic Reviews and led by an Upstate Medical University professor, has found that compared with standard antibiotic treatment, stool transplantation can increase the ...
Apr 24, 2023
0
12
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin, which is also known ...
Mar 7, 2023
0
61
Preterm and low birth-weight babies are routinely given antibiotics to prevent—not just treat—infections, which they have a high risk of developing. A new study published in The Journal of Physiology has found that ...
Sep 8, 2022
0
158
A study by researchers at the Rutgers Ernest Mario School of Pharmacy finds that melatonin significantly reduces kidney failure in people being treated with the antibiotic vancomycin.
Sep 15, 2021
0
142
(HealthDay)—Use of fidaxomicin and bezlotoxumab is suggested in specific cases for management of Clostridioides difficile infection (CDI), according to a clinical practice guideline update issued by the Infectious Diseases ...
Jul 12, 2021
0
2
A quality improvement initiative in the Neonatal Intensive Care Unit (NICU) at Children's National Hospital led to a significant reduction in treatment with intravenous vancomycin, an antibiotic used for resistant gram positive ...
Jul 1, 2020
0
0
Vancomycin (INN) (pronounced /ˌvæŋkɵˈmaɪsɪn/) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and daptomycin.
This text uses material from Wikipedia, licensed under CC BY-SA
